Open AccessS0984 Long-Term Efficacy and Safety of Obeticholic Acid in Patients With Primary Biliary Cholangitis: A Demographic Subgroup Analysis of 5-Year Results From the POISE Trial
Author(s) -
Christopher L. Bowlus,
Michael Trauner,
Frederik Nevens,
Paul J. Pockros,
Leigh MacConell,
A. Sender Liberman,
Elizabeth Smoot Malecha
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000705984.27144.9d
Subject(s) - obeticholic acid , medicine , ursodeoxycholic acid , primary biliary cirrhosis , placebo , adverse effect , gastroenterology , subgroup analysis , randomized controlled trial , confidence interval , pathology , alternative medicine , receptor , agonist